About GlySure
GlySure is a company based in Abingdon (United Kingdom) founded in 2006.. GlySure has raised $24.5 million across 2 funding rounds from investors including Amadeus Capital Partners, Delta Partners and Morningside China. The company has 41 employees as of March 31, 2018. GlySure operates in a competitive market with competitors including ZOLL AEDs, Attune Medical, InnAccel, ART Medical and Glucoset, among others.
- Headquarter Abingdon, United Kingdom
- Employees 41 as on 31 Mar, 2018
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Glysure Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24.5 M (USD)
in 2 rounds
-
Latest Funding Round
$13.6 M (USD), Series C
Nov 28, 2012
-
Investors
Amadeus Capital Partners
& 3 more
-
Employee Count
41
as on Mar 31, 2018
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of GlySure
GlySure has successfully raised a total of $24.5M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $13.6 million completed in November 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $13.6M
-
First Round
First Round
(09 Jan 2012)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2012 | Amount | Series C - GlySure | Valuation |
investors |
|
| Jan, 2012 | Amount | Series C - GlySure | Valuation | Morningside |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GlySure
GlySure has secured backing from 4 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Amadeus Capital Partners, Delta Partners and Morningside China. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage deep technology investments are made by Amadeus Capital.
|
Founded Year | Domain | Location | |
|
Early stage venture capital is provided to Irish startups.
|
Founded Year | Domain | Location | |
|
VC and private equity investments are made in China-US companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GlySure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GlySure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glysure Comparisons
Competitors of GlySure
GlySure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZOLL AEDs, Attune Medical, InnAccel, ART Medical and Glucoset, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices and software for emergency care are developed.
|
|
| domain | founded_year | HQ Location |
Patient temperature is modulated via esophageal cooling devices.
|
|
| domain | founded_year | HQ Location |
Diversified medical devices are manufactured for critical and maternal care.
|
|
| domain | founded_year | HQ Location |
Safe enteral nourishment products for ICU patients are developed.
|
|
| domain | founded_year | HQ Location |
Continuous intravascular blood glucose monitoring devices are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Glysure
Frequently Asked Questions about GlySure
When was GlySure founded?
GlySure was founded in 2006 and raised its 1st funding round 6 years after it was founded.
Where is GlySure located?
GlySure is headquartered in Abingdon, United Kingdom. It is registered at Abingdon, Oxfordshire, United Kingdom.
Is GlySure a funded company?
GlySure is a funded company, having raised a total of $24.5M across 2 funding rounds to date. The company's 1st funding round was a Series C of $10.9M, raised on Jan 09, 2012.
How many employees does GlySure have?
As of Mar 31, 2018, the latest employee count at GlySure is 41.
What does GlySure do?
GlySure has developed a continuous intravascular (I.V) glucose monitoring system using a proprietary optical fluorescence sensor for implementation of Tight Glycemic Control (TGC) in the hospital Intensive Care Unit (ICU). The company claims to have demonstrated through ICU testing highly accurate sensors which can provide continuous glucose readings throughout the length of a patients stay in the ICU. Also, the company mentions that hospital TGC has shown in prospective outcomes trials to produce significant improvement in patient outcomes including 46 reduction in incidence of sepsis, 41 reduction in renal failure, and 34 reduction in mortality. As of December 2016, the Company is finalizing design of a clinical trial to support submission to the U.S. Food and Drug Administration (FDA).
Who are the top competitors of GlySure?
GlySure's top competitors include ZOLL AEDs, Inspiration Healthcare and InnAccel.
Who are GlySure's investors?
GlySure has 4 investors. Key investors include Amadeus Capital Partners, Delta Partners, Morningside China, and Frank A Bonsal.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.